Barings’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,414
| Closed | -$371K | – | 161 |
|
|
2022
Q4 | $371K | Sell |
1,414
-490
| -26% | -$131K | 0.01% | 153 |
|
|
2022
Q3 | $429K | Sell |
1,904
-3,194
| -63% | -$774K | 0.02% | 140 |
|
|
2022
Q2 | $1.24M | Buy |
5,098
+3,028
| +146% | +$742K | 0.04% | 151 |
|
|
2022
Q1 | $500K | Sell |
2,070
-1,805
| -47% | -$415K | 0.02% | 203 |
|
|
2021
Q4 | $872K | Buy |
3,875
+570
| +17% | +$120K | 0.02% | 198 |
|
|
2021
Q3 | $703K | Sell |
3,305
-1,251
| -27% | -$288K | 0.02% | 212 |
|
|
2021
Q2 | $1.11M | Sell |
4,556
-340
| -7% | -$83.6K | 0.03% | 204 |
|
|
2021
Q1 | $1.22M | Sell |
4,896
-267
| -5% | -$63.7K | 0.03% | 210 |
|
|
2020
Q4 | $1.19M | Sell |
5,163
-39,947
| -89% | -$9.21M | 0.03% | 213 |
|
|
2020
Q3 | $11.5M | Sell |
45,110
-2,807
| -6% | -$695K | 0.26% | 61 |
|
|
2020
Q2 | $9.71M | Hold |
47,917
| – | – | 0.32% | 60 |
|
|
2020
Q1 | $9.71M | Buy |
47,917
+1,250
| +3% | +$273K | 0.33% | 60 |
|
|
2019
Q4 | $11.3M | Buy |
46,667
+5,265
| +13% | +$1.16M | 0.3% | 58 |
|
|
2019
Q3 | $8.01M | Buy |
41,402
+1,817
| +5% | +$349K | 0.18% | 117 |
|
|
2019
Q2 | $7.29M | Sell |
39,585
-29,498
| -43% | -$5.28M | 0.16% | 127 |
|
|
2019
Q1 | $13.1M | Buy |
69,083
+8,588
| +14% | +$1.64M | 0.3% | 65 |
|
|
2018
Q4 | $11.8M | Sell |
60,495
-63,202
| -51% | -$12.3M | 0.21% | 81 |
|
|
2018
Q3 | $25.6M | Buy |
123,697
+36,965
| +43% | +$7.28M | 0.36% | 46 |
|
|
2018
Q2 | $16M | Buy |
86,732
+12,691
| +17% | +$2.24M | 0.23% | 76 |
|
|
2018
Q1 | $12.6M | Sell |
74,041
-3,100
| -4% | -$569K | 0.18% | 94 |
|
|
2017
Q4 | $13.4M | Buy |
77,141
+40,435
| +110% | +$7.16M | 0.17% | 101 |
|
|
2017
Q3 | $6.84M | Sell |
36,706
-12,580
| -26% | -$2.23M | 0.12% | 109 |
|
|
2017
Q2 | $8.49M | Sell |
49,286
-103,312
| -68% | -$16.8M | 0.25% | 82 |
|
|
2017
Q1 | $25M | Buy |
152,598
+86,032
| +129% | +$14.3M | 0.28% | 56 |
|
|
2016
Q4 | $9.73M | Buy |
66,566
+2,230
| +3% | +$336K | 0.24% | 41 |
|
|
2016
Q3 | $10.7M | Sell |
64,336
-36,110
| -36% | -$6.11M | 0.28% | 35 |
|
|
2016
Q2 | $15.3M | Buy |
100,446
+18,150
| +22% | +$2.82M | 0.39% | 21 |
|
|
2016
Q1 | $12.3M | Sell |
82,296
-9,050
| -10% | -$1.34M | 0.33% | 34 |
|
|
2015
Q4 | $14.8M | Sell |
91,346
-13,400
| -13% | -$2.11M | 0.37% | 32 |
|
|
2015
Q3 | $14.5M | Sell |
104,746
-6,930
| -6% | -$1.09M | 0.36% | 33 |
|
|
2015
Q2 | $17.1M | Buy |
111,676
+1,750
| +2% | +$280K | 0.52% | 34 |
|
|
2015
Q1 | $17.6M | Buy |
109,926
+11,150
| +11% | +$1.76M | 0.4% | 26 |
|
|
2014
Q4 | $15.7M | Sell |
98,776
-5,430
| -5% | -$846K | 0.35% | 32 |
|
|
2014
Q3 | $14.6M | Buy |
104,206
+38,580
| +59% | +$5.04M | 0.32% | 45 |
|
|
2014
Q2 | $7.77M | Sell |
65,626
-5,330
| -8% | -$617K | 0.23% | 92 |
|
|
2014
Q1 | $8.75M | Buy |
70,956
+4,570
| +7% | +$554K | 0.27% | 66 |
|
|
2013
Q4 | $7.58M | Buy |
66,386
+9,300
| +16% | +$1.06M | 0.32% | 65 |
|
|
2013
Q3 | $6.39M | Sell |
57,086
-18,240
| -24% | -$1.98M | 0.27% | 78 |
|
|
2013
Q2 | $7.43M | Buy |
+75,326
| New | +$7.82M | 0.33% | 62 |
|
Other funds holding AMGN
Barings's AMGN Position: Q1 2023 in Review
Barings sold out of Amgen (AMGN) in Q1 2023, closing a stake of 1,414 shares — an estimated $371K sold.
Barings first reported a position in AMGN in Q2 2013 and held it in 39 quarters. The position peaked at $25.6M in Q3 2018. 2,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2023.
- Barings reported no remaining Amgen position as of Q1 2023 after selling out during the quarter.
- Barings sold 1,414 Amgen shares in Q1 2023, an estimated $371K.
- Barings first reported a position in Amgen in Q2 2013 and held it in 39 quarters.
- Barings's Amgen position peaked at $25.6M in Q3 2018.
- 2,434 funds tracked by Wall St. Rank held Amgen as of Q1 2023.
Based on Barings's 13F filing for Q1 2023, filed 9 May 2023.